JDVSX
Price
$16.48
Change
+$0.12 (+0.73%)
Updated
Jun 26 closing price
Net Assets
471.43M
RLBCX
Price
$36.18
Change
+$0.26 (+0.72%)
Updated
Jun 26 closing price
Net Assets
247.64B
Interact to see
Advertisement

JDVSX vs RLBCX

Header iconJDVSX vs RLBCX Comparison
Open Charts JDVSX vs RLBCXBanner chart's image
JPMorgan Diversified I
Price$16.48
Change+$0.12 (+0.73%)
VolumeN/A
Net Assets471.43M
American Funds American Balanced R3
Price$36.18
Change+$0.26 (+0.72%)
VolumeN/A
Net Assets247.64B
JDVSX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDVSX vs. RLBCX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVSX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 248B vs. JDVSX (471M). JDVSX pays higher dividends than RLBCX: JDVSX (2.52) vs RLBCX (1.63). JDVSX was incepted earlier than RLBCX: JDVSX (24 years) vs RLBCX (23 years). JDVSX (0.97) is less costly to investors than RLBCX (0.89). JDVSX is a more actively managed with annual turnover of: 63.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JDVSX: RLBCX (250) vs JDVSX (1000000). RLBCX (7.01) and JDVSX (6.87) have marching annual gain over last year. RLBCX return over 5 years is better than : 40.82 vs. JDVSX (14.33).
JDVSXRLBCXJDVSX / RLBCX
Total Expense Ratio0.710.8980%
Annual Report Gross Expense Ratio0.970.89109%
Fund Existence24 years23 years-
Gain YTD5.5166.56284%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets471M248B0%
Annual Yield % from dividends2.521.63154%
Returns for 1 year6.877.0198%
Returns for 3 years22.8631.5972%
Returns for 5 years14.3340.8235%
Returns for 10 years15.0460.7625%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTRN31.150.50
+1.63%
Citi Trends
VRRM25.310.30
+1.20%
Verra Mobility Corp
NTLA9.610.05
+0.52%
Intellia Therapeutics
IT404.601.96
+0.49%
Gartner
GBIO0.36-0.01
-2.63%
Generation Bio Co